Industry group says treatments may need to be restricted to the most overweight
Demand for weight loss drugs is becoming so “unsustainable” that demand may soon outstrip supply, pharmacists have warned.
The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved.
The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the “worried well”, it added.
That’s a valid response in the long term, but in the immediate/near term, it’s reasonable to want to restrict a treatment to those it’ll help most.
GLP drugs were widely available up until recently — because they stopped allowing pharmacies to compound the drug.
https://www.everydayhealth.com/weight-management/fda-ban-glp1-semaglutide-tirzepatide/
https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize